1. Ahmad, U, Fatimi, SH, Naqvi, I, et al. Modified Blalock–Taussig shunt: immediate and short-term follow-up results in neonates. Heart Lung Circ 2008; 17: 54–58.
2. Guzzetta, NA, Foster, GS, Mruthinti, N, Kilgore, PD, Miller, BE, Kanter, KR. In-hospital shunt occlusion in infants undergoing a modified Blalock–Taussig shunt. Ann Thorac Surg 2013; 96: 176–182.
3. Gedicke, M, Morgan, G, Parry, A, Martin, R, Tulloh, R. Risk factors for acute shunt blockage in children after modified Blalock–Taussig shunt operations. Heart Vessels 2010; 25: 405–409.
4. Celestin, C, Guillot, M, Ross-Ascuitto, N, Ascuitto, R. Computational fluid dynamics characterization of blood flow in central aorta to pulmonary artery connections: importance of shunt angulation as a determinant of shear stress-induced thrombosis. Pediatr Cardiol. 2015; 36: 600–615.
5. Adipurnama, I, Yang, MC, Ciach, T, Butruk-Raszeja, B. Surface modification and endothelialization of polyurethane for vascular tissue engineering applications: a review. Biomater Sci 2016; 5: 22–37.
6. Toulon, P, Berruyer, M, Brionne-Francois, M, et al. Age dependency for coagulation parameters in paediatric populations. Results of a multicentre study aimed at defining the age-specific reference ranges. Thromb Haemost 2016; 116: 9–16.
7. Del Vecchio, A, Motta, M, Romagnoli, C. Neonatal platelet function. Clin Perinatol 2015; 42: 625–638.
8. Mir, A, Frank, S, Journeycake, J, et al. Aspirin resistance in single-ventricle physiology: aspirin prophylaxis is not adequate to inhibit platelets in the immediate postoperative period. Ann Thorac Surg 2015; 99: 2158–2164.
9. Agarwal, A, Firdouse, M, Brar, N, et al. Incidence and management of thrombotic and thromboembolic complications following the Norwood procedure: a systematic review. Clin Appl Thromb/Hemost: Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2017; 23: 911–921.
10. Li, JS, Yow, E, Berezny, KY, et al. Clinical outcomes of palliative surgery including a systemic-to-pulmonary artery shunt in infants with cyanotic congenital heart disease: does aspirin make a difference? Circulation 2007; 116: 293–297.
11. Emani, S, Trainor, B, Zurakowski, D, et al. Aspirin unresponsiveness predicts thrombosis in high-risk pediatric patients after cardiac surgery. J Thorac Cardiovasc Surg 2014; 148: 810–814; discussion 4-6.
12. Heistein, LC, Scott, WA, Zellers, TM, et al. Aspirin resistance in children with heart disease at risk for thromboembolism: prevalence and possible mechanisms. Pediatr Cardiol 2008; 29: 285–291.
13. Truong, DT, Johnson, JT, Bailly, DK, et al. Platelet inhibition in shunted infants on aspirin at short and midterm follow-up. Pediatr Cardiol 2017; 38: 401–409.
14. Lev, EI, Solodky, A, Harel, N, et al. Treatment of aspirin-resistant patients with omega-3 fatty acids versus aspirin dose escalation. J Am Coll Cardiol 2010; 55: 114–121.
15. Gurbel, PA, Bliden, KP, DiChiara, J, et al. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study. Circulation 2007; 115: 3156–3164.
16. Monagle, P, Chan, AKC, Goldenberg, NA, et al. Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (Suppl 2): e737S–e801S.
17. Cholette, JM, Rubenstein, JS, Alfieris, GM, et al. Elevated risk of thrombosis in neonates undergoing initial palliative cardiac surgery. Ann Thorac Surg 2007; 84: 1320–1325.
18. Fenton, KN, Siewers, RD, Rebovich, B, Pigula, FA. Interim mortality in infants with systemic-to-pulmonary artery shunts. Ann Thorac Surg 2003; 76: 152–156; discussion 6-7.
19. Rajasekhar, D, Kestin, AS, Bednarek, FJ, Ellis, PA, Barnard, MR, Michelson, AD. Neonatal platelets are less reactive than adult platelets to physiological agonists in whole blood. Thromb Haemost 1994; 72: 957–963.
20. Straub, A, Smolich, J, d’Udekem, Y, Brizard, C, Peter, K, Horton, S. Activation of platelets in young infants during cardiopulmonary bypass. Thromb Haemost 2010; 103: 466–469.
21. Manlhiot, C, Brandao, LR, Kwok, J, et al. Thrombotic complications and thromboprophylaxis across all three stages of single ventricle heart palliation. J Pediatr 2012; 161: 513–519 e3.
22. Todd Tzanetos, DR, Yu, C, Hernanz-Schulman, M, Barr, FE, Brown, NJ. Prospective study of the incidence and predictors of thrombus in children undergoing palliative surgery for single ventricle physiology. Intensive Care Med 2012; 38: 105–112.
23. Redford, DT, Paidy, SR, Steinbrenner, EB, Nielsen, VG. Effects of profound hypoxemia on coagulation & fibrinolysis in normal individuals. Blood Coagul Fibrinolysis: An International Journal in Haemostasis and Thrombosis 2016; 27: 228–231.
24. Mace, S, Borkat, G, Liebman, J. Hepatic dysfunction and cardiovascular abnormalities. Occurrence in infants, children, and young adults. Am J Dis Child 1985; 139: 60–65.
25. Haga, P, Cotes, PM, Till, JA, Minty, BD, Shinebourne, EA. Serum immunoreactive erythropoietin in children with cyanotic and acyanotic congenital heart disease. Blood. 1987; 70: 822–826.
26. Cholette, JM, Swartz, MF, Rubenstein, J, et al. Outcomes using a conservative versus liberal red blood cell transfusion strategy in infants requiring cardiac operation. Ann Thorac Surg 2017; 103: 206–214.
27. Garcia-Roa, M, Del Carmen Vicente-Ayuso, M, Bobes, AM, et al. Red blood cell storage time and transfusion: current practice, concerns and future perspectives. Blood Transfus. 2017; 15: 222–231.
28. Anderson, BR, Blancha, VL, Duchon, JM, et al. The effects of postoperative hematocrit on shunt occlusion for neonates undergoing single ventricle palliation. J Thorac Cardiovasc Surg 2017; 153: 947–955.
29. Sahoo, TK, Chauhan, S, Sahu, M, Bisoi, A, Kiran, U. Effects of hemodilution on outcome after modified Blalock-Taussig shunt operation in children with cyanotic congenital heart disease. J Cardiothorac Vasc Anesth 2007; 21: 179–183.
30. Manlhiot, C, McCrindle, BW, Menjak, IB, et al. Longer blood storage is associated with suboptimal outcomes in high-risk pediatric cardiac surgery. Ann Thorac Surg 2012; 93: 1563–1569.
31. Howard-Quijano, K, Schwarzenberger, JC, Scovotti, JC, et al. Increased red blood cell transfusions are associated with worsening outcomes in pediatric heart transplant patients. Anesth Analg 2013; 116: 1295–1308.
32. Dasgupta, R, Parsons, A, McClelland, S, et al. Association of haematocrit and red blood cell transfusion with outcomes in infants with shunt-dependent pulmonary blood flow and univentricular physiology. Blood Transfus 2015; 13: 417–422.